Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.
作者信息
Costa-Filho Rubens C, Leite José Paulo G, Horta Marco Aurélio, Naveca Felipe Gomes, Saddy Felipe, Castro de Faria Neto Hugo C
机构信息
Laboratory of Immunopharmacology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
Estácio Medical School - IDOMED, Rio de Janeiro, Brazil.
出版信息
Front Med (Lausanne). 2025 May 16;12:1558264. doi: 10.3389/fmed.2025.1558264. eCollection 2025.
Abstract
摘要
相似文献
1
Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.评论：巴西严重急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 May 16;12:1558264. doi: 10.3389/fmed.2025.1558264. eCollection 2025.
2
Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.巴西重症急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2024 Dec 18;11:1495428. doi: 10.3389/fmed.2024.1495428. eCollection 2024.
3
Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.评论：巴西严重急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 May 16;12:1558299. doi: 10.3389/fmed.2025.1558299. eCollection 2025.
4
Expression of concern: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.关注声明：巴西确诊为严重急性呼吸综合征病例的新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 Jan 15;12:1561115. doi: 10.3389/fmed.2025.1561115. eCollection 2025.
5
Retraction: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.撤稿声明：巴西重症急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2025 May 16;12:1619451. doi: 10.3389/fmed.2025.1619451. eCollection 2025.
6
Mortality risk of Severe Acute Respiratory Syndrome cases classified as COVID-19: A longitudinal study.COVID-19 分类的严重急性呼吸综合征病例的死亡率：一项纵向研究。
PLoS One. 2024 Aug 30;19(8):e0309413. doi: 10.1371/journal.pone.0309413. eCollection 2024.
7
Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.巴西原住民中由严重急性呼吸综合征冠状病毒2感染或其他病原体引起的严重急性呼吸综合征：一项关于冠状病毒病（COVID）-19大流行第一年的观察性研究。
Lancet Reg Health Am. 2022 Apr;8:100177. doi: 10.1016/j.lana.2021.100177. Epub 2022 Jan 7.
8
Severe Acute Respiratory Syndrome (SARS) in the Context of the COVID-19 Pandemic Among Indigenous Peoples of Brazil: Epidemiology and Risk Factors Associated with Death.巴西原住民中 COVID-19 大流行背景下的严重急性呼吸综合征（SARS）：流行病学和与死亡相关的风险因素。
J Racial Ethn Health Disparities. 2024 Aug;11(4):1908-1917. doi: 10.1007/s40615-023-01660-z. Epub 2023 Jun 14.
10
Clinical, epidemiological and laboratory characteristics of cases of Covid-19-related maternal near miss and death at referral units in northeastern Brazil: a cohort study.巴西东北部转诊单位与新冠相关的孕产妇严重不良结局病例的临床、流行病学和实验室特征：一项队列研究。
J Matern Fetal Neonatal Med. 2023 Dec;36(2):2260056. doi: 10.1080/14767058.2023.2260056. Epub 2023 Sep 25.
本文引用的文献
1
Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.巴西重症急性呼吸综合征病例中新冠后死亡风险评估：一项中长期纵向研究
Front Med (Lausanne). 2024 Dec 18;11:1495428. doi: 10.3389/fmed.2024.1495428. eCollection 2024.
2
Severe acute respiratory infection surveillance in Brazil: the role of public, private and philanthropic healthcare units.巴西严重急性呼吸道感染监测：公立、私立和慈善医疗机构的作用。
Health Policy Plan. 2022 Oct 12;37(9):1075-1085. doi: 10.1093/heapol/czac050.
3
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.Covid-19 疫苗对 B.1.617.2（德尔塔）变异株的有效性。
N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21.
4
Reduction in life expectancy in Brazil after COVID-19.巴西在经历了新冠疫情后预期寿命缩短。
Nat Med. 2021 Sep;27(9):1629-1635. doi: 10.1038/s41591-021-01437-z. Epub 2021 Jun 29.
5
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
6
Characterisation of the first 250,000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data.巴西 25 万例 COVID-19 住院患者的特征：全国范围内数据的回顾性分析。
Lancet Respir Med. 2021 Apr;9(4):407-418. doi: 10.1016/S2213-2600(20)30560-9. Epub 2021 Jan 15.
7
Introduction to the Analysis of Survival Data in the Presence of Competing Risks.存在竞争风险时生存数据的分析导论
Circulation. 2016 Feb 9;133(6):601-9. doi: 10.1161/CIRCULATIONAHA.115.017719.
Zotero 插件